Results 251 to 260 of about 11,167,014 (325)
Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome
HemaSphere, Volume 10, Issue 11, November 2026.Bhavisha A. Patel, Ajoy Dias, Daniele Avila, Tonya Jenkins, Lisa Duncan, Roxanne Merkel, Alice Fike, Julie Onyechi, Xingmin Feng, Fernanda Gutierrez‐Rodrigues, Ivana Darden, Shanni Liu, Benjamin Turturice, Jennifer Hendricks, Erin Flannelly, Kristen Cole, Kanak Parmar, Ruba Shalhoub, Colin O. Wu, Jennifer Lotter, Boeui Kang, Sachiko Kajigaya, Corina Gonzalez, Chuanfeng Wu, Marcela A. Ferrada, Jennifer Cuellar‐Rodriguez, Mary Czech, Katherine R. Calvo, Richard W. Childs, David B. Beck, Neal S. Young, Sung‐Yun Pai, Dennis D. Hickstein, Peter C. Grayson, Emma M. Groarke +34 morewiley +1 more sourcePrevalence of Hepatitis C Infection and Treatment Initiation Following Dried Blood Spot Testing in New South Wales, Australia
Liver International, Volume 46, Issue 11, November 2026.ABSTRACT Background and Aims
To achieve hepatitis C (HCV) elimination by 2030, testing and treatment must reach people most at risk. Dried blood spot (DBS) testing offers an alternative to venepuncture, suitable for community and prison settings. This study evaluated HCV infection prevalence and treatment initiation among people receiving DBS testing ...Annabelle Stevens, Anna Conway, Nigel Carrington, Evan B. Cunningham, Alison D. Marshall, Janaki Amin, Phillip Read, Tracey Brown, Rick Varma, Bianca Prain, Philip Cunningham, Gregory J. Dore, Jason Grebely +12 morewiley +1 more sourceFucosylation limits ADCC in clinically used anti‐RhD monoclonal antibodies
Transfusion, Volume 66, Issue 11, Page 2360-2372, November 2026.Abstract Background
Haemolytic disease of the fetus and newborn (HDFN) is caused by maternal alloantibodies, often targeting the D antigen on fetal red blood cells. Maternal immunization is preventable with timely administration of anti‐D polyclonal antibodies (pAbs).Gabriela Koike, Albert Bondt, Douwe Schulte, Rien Leuvenink, Dirk Jan Mons, Peter C. Ligthart, E. Joanne T. Verweij, AFRICARhE Consortium, Enrico Lopriore, E. J. T. Joanne Verweij, Tienke Vermeiden, Thomas van den Akker, C. Ellen van der Schoot, Derek P. de Winter, Renske van Oever, Abera Kenay Tura, Tadesse Gure, Assefa Desalew, Tewodros Tesfa, Konjit Eshetu, Jeremia Pyuza, Rafiki N. Mjema, Priscus John Mapendo, Jeremiah John Hhera, Bariki Mchome, Patricia Swai, Blandina T. Mmbaga, Aisa Shayo, Peter Moons, Kondwani Kawaza, Luis Gadama, Albert J. R. Heck, C. Ellen van der Schoot, Gestur Vidarsson +33 morewiley +1 more sourceInvestigating the molecular basis of the serological Rh D‐negative phenotype in Indonesia: nature, frequency, and impact for diagnostics
Transfusion, Volume 66, Issue 11, Page 2244-2252, November 2026.Abstract Background
Although widely studied and reported for more than 30 years, the molecular basis of Rh D‐negativity has remained unexplored in several regions of the world, including in Indonesia, Southeast Asia. Study Design and Methods
A subset of 436 Indonesian blood donors originally typed D‐negative (D–) by routine serological testing was ...Tonny Wongso, Teguh Triyono, Caroline Bénech, Gauthier Thomas, Sasi Widuri, Martono Adi Triyogo, Ni Kadek Mulyantari, Misnah Syarifuddin, Halimi Maksum, Winda Astuti Taruno, Hasna Fadlilatul Bidayah, Yann Fichou +11 morewiley +1 more sourceAABB survey on directed blood donation practices
Transfusion, Volume 66, Issue 11, Page 2233-2243, November 2026.Abstract Background
Standardized guidance regarding the processes for collecting directed blood donations (DBD) is lacking, leading to variable practices. This study assessed laboratory, clinical, and charging practices for DBD collection in the United States and Canada. Study Design and Methods
An electronic survey was distributed to United States and Nabiha H. Saifee, Emily Coberly, Brian D. Adkins, Louise Helander, Nancy Robitaille, Laura K. Dilly, Lani Lieberman +6 morewiley +1 more sourceThe lymphocyte function of allogeneic peripheral blood stem cell grafts is associated with relapse and cytomegalovirus reactivation
Transfusion, Volume 66, Issue 11, Page 2302-2312, November 2026.Abstract Background
Allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment primarily for hematological malignancies. Infections, relapse, and graft versus host disease (GvHD) are some of the most common adverse events following HSCT. We aimed to evaluate whether the lymphocyte function of the stem cell graft was associated with these ...Anna Söderström, Tengyu Wang, Johan Törlén, Hannes Lindahl, Davide Valentini, Stephan Mielke, Klara Asplund Högelin, Rebecca Axelsson Robertson, Michael Uhlin +8 morewiley +1 more sourceBreakthrough Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: Mechanistic Insights and Management Strategies
Transfusion, Volume 66, Issue 11, Page 2421-2431, November 2026.Abstract Background
Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic stem cell disorder caused by somatic mutations in the PIGA gene, resulting in loss of glycosylphosphatidylinositol (GPI)‐anchored proteins, including the complement regulatory proteins, CD55 and CD59.Ganesh Raman, Meghana Vivek, Rida Hasan, Siobán Keel, Laura Connelly‐Smith +4 morewiley +1 more sourcePretransfusion testing interference profile of IMC‐002: A novel anti‐CD47 monoclonal antibody engineered for minimized red cell binding
Transfusion, Volume 66, Issue 11, Page 2323-2334, November 2026.Abstract Background
CD47‐targeted agents can interfere with pretransfusion testing due to CD47 expression on red blood cells (RBCs). IMC‐002 is a novel anti‐CD47 human IgG4 monoclonal antibody engineered to minimize RBC binding; however, its interference profile during pretransfusion testing remains poorly characterized.Tae‐Shin Kim, Jae Hyeon Park, Yousun Chung, Dae‐Hyun Ko, Seon Young Kim, Hyungsuk Kim +5 morewiley +1 more sourceMapping obstetric biobanks: A scoping review highlighting gaps in the study of alloimmunized pregnancies
Transfusion, Volume 66, Issue 11, Page 2373-2384, November 2026.Abstract Background
Maternal red cell alloimmunization can cause hemolytic disease of the fetus and newborn (HDFN), yet prediction of disease severity remains limited. Biobanks that link pregnancy biospecimens with clinical and laboratory data could accelerate translational research; however, the landscape of relevant obstetric biobanks has not been ...Orlin Chowdhury, Chantal Armali, Catherine Devion, Sasha Kyser‐Burke, Akash Gupta, Noor Niyar N. Ladhani, Harley Meirovich, Hubert Tsui, Noah Zweig, Yulia Lin, Heather VanderMeulen +10 morewiley +1 more sourceImplementation of soluble CD38 in blood crossmatching for patients on anti‐CD38 therapy: A single‐center experience
Transfusion, Volume 66, Issue 11, Page 2097-2100, November 2026.Abstract Background
Human monoclonal (MoAb) anti‐CD38 antibodies, such as daratumumab, are used to treat diseases such as multiple myeloma. Because red blood cells (RBCs) express CD38, these MoAbs interfere with antibody screening and crossmatching in blood banks.Ayda Javanbakht, David Hanna, Grishma Amatya Jaspau, Ravi Sarode +3 morewiley +1 more source